Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 356

1.

Semiquantitative analysis of maximum standardized uptake values of regional lymph nodes in inflammatory breast cancer: is there a reliable threshold for differentiating benign from malignant?

Carkaci S, Adrada BE, Rohren E, Wei W, Quraishi MA, Mawlawi O, Buchholz TA, Yang W.

Acad Radiol. 2012 May;19(5):535-41. doi: 10.1016/j.acra.2012.01.001. Epub 2012 Feb 1.

2.

[Differentiation of malignant and benign superficial lymph nodes by dual time point 18F-FDG PET].

Su MG, Fan QP, Tian Y, Li FL, Yang XC, Li L, Fan CZ, Tian R.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2009 May;40(3):517-20. Chinese.

PMID:
19627018
3.

Clinical significance of combined assessment of the maximum standardized uptake value of F-18 FDG PET with nodal size in the diagnosis of cervical lymph node metastasis of oral squamous cell carcinoma.

Matsubara R, Kawano S, Chikui T, Kiyosue T, Goto Y, Hirano M, Jinno T, Nagata T, Oobu K, Abe K, Nakamura S.

Acad Radiol. 2012 Jun;19(6):708-17. doi: 10.1016/j.acra.2012.02.009. Epub 2012 Apr 7.

PMID:
22484437
4.

Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma.

Kuo WH, Wu YC, Wu CY, Ho KC, Chiu PH, Wang CW, Chang CJ, Yu CT, Yen TC, Lin C.

Acad Radiol. 2012 Jun;19(6):685-92. doi: 10.1016/j.acra.2012.02.013. Epub 2012 Mar 28.

PMID:
22459646
5.
6.

Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patients.

Hahn S, Hecktor J, Grabellus F, Hartung V, Pöppel T, Kimmig R, Forsting M, Antoch G, Heusner TA.

Acta Radiol. 2012 Jun 1;53(5):518-23. doi: 10.1258/ar.2012.110420. Epub 2012 Apr 30.

PMID:
22547387
7.

[Density and SUV ratios from PET/CT in the detection of mediastinal lymph node metastasis in non-small cell lung cancer].

Shao T, Yu L, Li Y, Chen M.

Zhongguo Fei Ai Za Zhi. 2015 Mar;18(3):155-60. doi: 10.3779/j.issn.1009-3419.2015.03.05. Chinese.

8.

Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.

Hashimoto Y, Tsujikawa T, Kondo C, Maki M, Momose M, Nagai A, Ohnuki T, Nishikawa T, Kusakabe K.

J Nucl Med. 2006 Mar;47(3):426-31.

9.

18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?

Hellwig D, Graeter TP, Ukena D, Groeschel A, Sybrecht GW, Schaefers HJ, Kirsch CM.

J Nucl Med. 2007 Nov;48(11):1761-6. Epub 2007 Oct 17.

10.

Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non-Small-Cell Lung Cancer.

Mattes MD, Moshchinsky AB, Ahsanuddin S, Rizk NP, Foster A, Wu AJ, Ashamalla H, Weber WA, Rimner A.

Clin Lung Cancer. 2015 Nov;16(6):e253-8. doi: 10.1016/j.cllc.2015.06.001. Epub 2015 Jun 15.

PMID:
26163919
11.
12.

The value of dual-time-point 18F-FDG PET/CT for identifying axillary lymph node metastasis in breast cancer patients.

Choi WH, Yoo IR, O JH, Kim SH, Chung SK.

Br J Radiol. 2011 Jul;84(1003):593-9. doi: 10.1259/bjr/56324742. Epub 2010 Nov 16.

13.

Dual-phase F-18 FDG PET-CT in staging and lymphoscintigraphy for detection of sentinel lymph nodes in oral cavity cancers.

Sürücü E, Polack BD, Demir Y, Durmuşoğlu M, Ekmekçi S, Sarıoğlu S, Çelik AO, Ada E, İkiz AÖ.

Clin Imaging. 2015 Sep-Oct;39(5):781-6. doi: 10.1016/j.clinimag.2015.02.004. Epub 2015 Feb 12.

PMID:
25721710
14.
15.

Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients.

An YS, Lee DH, Yoon JK, Lee SJ, Kim TH, Kang DK, Kim KS, Jung YS, Yim H.

Nuklearmedizin. 2014;53(3):89-94. doi: 10.3413/Nukmed-0605-13-06. Epub 2013 Nov 13.

PMID:
24220324
16.

18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer.

Song BI, Lee SW, Jeong SY, Chae YS, Lee WK, Ahn BC, Lee J.

J Nucl Med. 2012 Sep;53(9):1337-44. doi: 10.2967/jnumed.111.098640. Epub 2012 Jun 29.

17.

Supraclavicular lymph nodes detected by 18F-FDG PET/CT in cancer patients: assessment with 18F-FDG PET/CT and sonography.

Lee JH, Kim J, Moon HJ, Cho A, Yun M, Lee JD, Kang WJ.

AJR Am J Roentgenol. 2012 Jan;198(1):187-93. doi: 10.2214/AJR.11.6999.

PMID:
22194496
18.

Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer.

Ueda S, Tsuda H, Asakawa H, Omata J, Fukatsu K, Kondo N, Kondo T, Hama Y, Tamura K, Ishida J, Abe Y, Mochizuki H.

BMC Cancer. 2008 Jun 9;8:165. doi: 10.1186/1471-2407-8-165.

19.

[The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].

Xu HF, Liu Y, Zhang JH, Zhou RS, Zhou FH, Yuan MH.

Zhonghua Jie He He Hu Xi Za Zhi. 2005 Feb;28(2):108-11. Chinese.

PMID:
15854393
20.

Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.

Herbrik M, Treffert J, Geiger B, Riegger C, Hartung V, Rosenbaum-Krumme SJ, Forsting M, Antoch G, Heusner TA.

J Nucl Med. 2011 Oct;52(10):1520-5. doi: 10.2967/jnumed.111.092593. Epub 2011 Sep 9.

Supplemental Content

Support Center